• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Greenwich LifeSciences, Inc.

    Greenwich LifeSciences Provides Year End Update
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2023
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences Announces Activation of Clinical Sites and Commencement of Phase III Clinical Trial
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences Provides Financing Strategy & Corporate Update
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to Proceed
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences Announces Suspension of Share Repurchase Program
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences to Resume Stock Repurchase Program
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences Provides Updates on Upcoming Phase III Clinical Trial & ASCO Meeting
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences to Participate in Upcoming Jefferies, Wainwright, ASCO and BIO International Conferences
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences Presents Phase IIb Data, Published at AACR 2022, Further Supporting the Role of GP2 in Preventing Metastatic Breast Cancer
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences to Present at 2022 BIO CEO & Investor Conference
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences Provides Update on Upcoming Phase III Clinical Trial, FLAMINGO-01
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences to Implement Stock Repurchase Program for up to $10 Million & to Extend Lock-up of Insiders for an Additional 1 Year
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences CEO Participates in TD Ameritrade Interview to Discuss 2021 SABCS Poster
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences Announces Presentation of 5 Year Data for GP2 Phase IIb Clinical Trial, Revealing Potential For New T Cell Platform Technology
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences to Participate in Multiple Interviews and Conferences
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences Expands Role of Industry Expert Dr. F. Joseph Daugherty to Include Medical Monitor for its Upcoming Phase III Clinical Trial
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences Announces Commencement of the First Commercial Line Filling of GP2
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences CEO Interview to Air on Bloomberg U.S. on the RedChip Money Report
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences to Participate in Jefferies’ 12th Annual London Healthcare Conference
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences Announces Acceptance of Two Posters at Upcoming 2021 SABCS Breast Cancer Conference
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences Provides Clinical Update on Upcoming Phase III Clinical Trial, FLAMINGO-01
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences Provides Updated Corporate Presentation and Webcasts
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences to Partner with Susan G. Komen Race for the Cure Houston
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences to Present at the Benzinga Healthcare Small Cap Conference
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences to Present at the Cantor Global Healthcare Conference
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences to Present at H.C. Wainwright 23rd Annual Global Investment Conference
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences Provides Updates on Recent and Upcoming Developments
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Greenwich LifeSciences to Participate in Citi’s 16th Annual Biopharma Virtual Conference
    From Greenwich LifeSciences, Inc.
    Via Business Wire
    Tickers GLSI
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.